India's healthcare industry faces three defining shifts as drug pricing, weight-loss innovation, and pharmaceutical R&D reshape patient access and competition.
Omron's Chennai factory puts medical device localization in focus as India seeks domestic production, component sourcing and a larger role in global healthcare supply chains.
Patient accommodation infrastructure is gaining attention as AIIMS Delhi prepares to use BEL's new 897-seat facility to improve support for patients and attendants.
The US FDA clears Sun Pharma’s Ilumya for adults with active psoriatic arthritis, expanding the drug beyond its original 2018 approval for moderate-to-severe plaque psoriasis.
India’s pharma export numbers for the first half of FY27 reach USD 16.14 billion, a 4.9% rise from USD 15.38 billion a year earlier
Autoimmune drug discovery is gaining attention as ICMR backs a four-year Indian study exploring genetic links and shared treatment targets across affected families nationally.
World markets drive Strides Pharma’s 17% rise this quarter as the company’s non-US markets generate more revenue than its traditional American business for the first time.
The London Biotechnology Show 2026 will return to ExCeL London on 18–19 November, bringing together biotechnology and pharmaceutical companies, researchers, healthcare professionals, investors, policymakers and technology providers
Philips' Oxygenate 5 launch puts home oxygen therapy access, affordability and long-term respiratory care in India under the spotlight as COPD-related healthcare needs grow nationally.
Health Ministry launches Tobacco Free Youth Campaign 4.0, targeting colleges and universities to close tobacco free gaps across Indian states.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
